Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells-Reference-Cited by-同舟云学术

Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells

Published:2016-02-09 Issue:1 Volume:14 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Shingu Takashi,Holmes Lindsay,Henry Verlene,Wang Qianghu,Latha Khatri,Gururaj Anupama E.,Gibson Laura A.,Doucette Tiffany,Lang Frederick F.,Rao Ganesh,Yuan Liang,Sulman Erik P.,Farrell Nicholas P.,Priebe Waldemar,Hess Kenneth R.,Wang Yaoqi A.,Hu Jian,Bögler Oliver

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-016-0803-2.pdf

Reference62 articles.

1. Wen PY, Kesari S. Malignant gliomas in adults. New Engl J Med. 2008;359:492–507.

2. Purow B, Schiff D. Advances in the genetics of glioblastoma: are we reaching critical mass? Nat Rev Neurol. 2009;5:419–26.

3. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, et al. The somatic genomic landscape of glioblastoma. Cell. 2013;155:462–77.